Francisco J. Márquez‐Malaver

Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

José Falantes, Cristina Calderón, Francisco J. Márquez‐Malaver et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 44 citations

Hematological Malignancy, Antibiotics, Antifungal Agents +10

Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial

Teresa Caballero‐Velázquez, Isabel Montero, Fermín Sánchez‐Guijo et al. · Clinical Cancer Research · 2016 · 44 citations · Full text

The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate

Josè Antonio Pérez-Simón, Rodrigo Martino, Rocío Parody et al. · Haematologica · 2012 · 40 citations · Full text

Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia

José Falantes, Pablo Trujillo, José I. Piruat et al. · Clinical Lymphoma Myeloma & Leukemia · 2014 · 37 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +7

Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma

Natasha Kekre, Francisco J. Márquez‐Malaver, Mónica Cabrero et al. · Biology of Blood and Marrow Transplantation · 2016 · 34 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +15